Potential of Saccharomyces cerevisiae fermentation-derived postbiotic technology in mitigating multiple drug-resistant Salmonella enterica serovars in an in vitro broiler cecal model

Saccharomyces cerevisiae fermentation-derived postbiotic technology (SCFP) is designed to interact synergistically with the animal to provide health benefits by enhancing immune function, supporting digestive integrity and absorption, and maintaining gastrointestinal (GIT) microbial balance in the host. SCFP effectively mitigated multiple MDR serovars of Salmonella under poultry cecal in vitro incubation conditions.